BioCentury
ARTICLE | Company News

GeneTrace Systems, Incyte Pharmaceuticals Inc. deal

March 25, 1996 8:00 AM UTC

INCY received a license to GeneTrace’s mass spectrometry technology and will collaborate with GeneTrace to develop specific DNA analysis applications. INCY will have exclusive access for a period of time to GeneTrace’s technology for identifying differential gene expression patterns for use by INCY’s database subscribers. ...